Blog

High turnover at clinical research sites is a significant challenge, leading to disrupted trials, increased costs, and a strained workforce. The reliance on temporary staff often exacerbates these issues. A new approach is needed—one that embeds experienced, sponsor-funded professionals directly at sites. This model helps provide stability, reduces financial burdens on sites, and improves trial continuity and patient experiences. By rethinking the staffing model, we can address the root causes of turnover and create a more sustainable framework for clinical trials.

As clinical trials become more complex and timelines stretch longer, effective industry collaboration isn’t just a nice-to-have—it’s mission critical. That’s why SCRS launched Collaborate Forward: a bold new initiative aimed at identifying and implementing real-world best practices for cross-industry coordination. With a data-driven playbook in development, we’re turning collaboration from a challenge into a competitive advantage. Explore how we’re tackling study feasibility, contracts, and patient recruitment—together.

Clinical trial budgeting is complex, especially with decentralized models and growing regulatory demands. In the UK, the Interactive Costing Tool (iCT) has helped standardize and streamline budget preparation. Now, with the integration of iCT data into Medidata’s Grants Manager Planning platform, there's growing interest in how automation and standardization can reduce administrative burdens, improve accuracy, and support fair compensation for research sites.

As clinical trials expand across borders, so do the challenges—and the opportunities. From navigating diverse regulations and logistics to ensuring a seamless, supportive patient experience, cross-border trials demand adaptability, cultural awareness, and a patient-first mindset. This post dives into the key complexities sponsors and sites must manage—and how collaboration and creativity can transform barriers into breakthroughs for global research.

Dr. Benjamin Marcum shares how partnering with an integrated research organization (IRO) transformed his small-town Texas clinic into a thriving clinical research site. With embedded staff and seamless support from Javara, Dr. Marcum has now led 18 trials—all while continuing his regular clinical responsibilities. Learn how this model brings new patients, reduces overhead, and keeps physicians connected to the cutting edge of medicine.

Site training holds a necessary place in clinical research, but the current framework lacks certain elements, hindering the true goals of successful training. What lessons can we draw from other industries that have demonstrated excellence and efficiency?